Just Other Articles
#1 in Business Subscribe Email Print

You are here: Home > Business > Negotiation > The Fine Art of Negotiation

Tags

  • still
  • person
  • should
  • companies involved
  • their cards

  • Links

  • Online Sweepstakes
  • The Wealth-Killing Attitude
  • Choosing the Right Home Business For You
  • Just Other Articles - The Fine Art of Negotiation

    It may sound like a trite phrase but truly negotiation is a learned skill. It is something that puts you personally and professionally i
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    n the driver's seat and once you have that skill, you can barter for goods in Tijuana or with major companies for goods and jobs.

    My fav
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    urite story about negotiation is one where a person gets a call from student loans people after many years on an old debt. And though, t
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    is doesn't somehow seem relevant, it is because of his reaction. Though he should knee jerk react thinking about his credit rating or th
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    whole sue him aspects, he doesn't. He says he'll look into it and though the person on the other side becomes belligerent, he is calm a
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    d cool. The other side in this conversation has showed all their cards. They have threatened to sue. They have threatened to wreck his
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    credit. Still, he persists that he will look into it. Knowing they have shown their hand, seven days later the same person phones back
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    and offers him 8,000 dollars off his loan if he goes out and gets a bank loan. And he still doesn't jump right to getting a bank loan.
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    e waits another week to see if the person will come down in price, after all he knows all too well that they've shown every single card t
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ey had. He's not afraid of being sued or having his credit destroyed. They don't have anything else and now they are bending to him.

    H
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    s skill here is listening to the other party as they laid their cards out and then not responding in an emotional way.

    Negotiation in it
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    truest sense means listening to the other party, trying to understand where they come from.

    It is the ultimate art of looking before yo
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    leap and not jumping to the handshake and the contract. Instead, the art is in refining what you want, setting those unstoppable goals
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    nd also leaving some wiggle room on stuff you don't truly care about.

    Say for example, you've been invited to merge your businesses temp
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    orarily. You go to the first meeting with a list of what you want out of it and you listen to the other side's list as well. You may at
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    this meeting agree on nothing at all or perhaps there is one thing. Everything else, you say you will go home and think about over the n
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    xt few days. But you take a week instead. This sets you up even more. If they really want the deal, you will have struck fear into the
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    r hearts. If they haven't fully showed their cards, they may now.

    In doing that, the other side often will counter to keep your interes
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    . By not showing your hand too much up front, you may be in a better position.

    Negotiations are not emotional. Refuse to act emotional
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    y and you are half way there. In addition, remember that the person who says little and shows the least cards maintains the most control


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.justotherarticles.org.ua/article/31101/justotherarticles-The-Fine-Art-of-Negotiation.html">The Fine Art of Negotiation</a>

    BB link (for phorums):
    [url=http://www.justotherarticles.org.ua/article/31101/justotherarticles-The-Fine-Art-of-Negotiation.html]The Fine Art of Negotiation[/url]

    Related Articles:

    Promoting Your Fundraiser

    Rules For Winning Interviews

    Discussion on Ethics of the MLM Sales Pitch

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com